title: JAK2 Val617Phe activating tyrosine kinase mutation in juvenile myelomonocytic leukemia.
authors.forename: C
authors.initials: C
authors.lastname: Tono
authors.forename: G
authors.initials: G
authors.lastname: Xu
authors.forename: T
authors.initials: T
authors.lastname: Toki
authors.forename: Y
authors.initials: Y
authors.lastname: Takahashi
authors.forename: S
authors.initials: S
authors.lastname: Sasaki
authors.forename: K
authors.initials: K
authors.lastname: Terui
authors.forename: E
authors.initials: E
authors.lastname: Ito
mesh_terms: D002675:Child, Preschool; D006801:Humans; D053614:Janus Kinase 2; D015477:Leukemia, Myelomonocytic, Chronic / Q000201:enzymology* / Q000235:genetics* / Q000628:therapy; D008297:Male; D009154:Mutation / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*
chemical_list: D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2